Cyclosporine A- and FK506-induced apoptosis in PC12 cells.

Cell Biol Toxicol

Department of Clinical Chemistry, Faculty of Pharmaceutical Sciences, Hokuriku University, Ho-3, Kanagawa-machi, Kanazawa, Ishikawa, 920-1148, Japan.

Published: September 2007

The purpose of this study was to examine, using glycogen synthase kinase (GSK) inhibitors, whether GSK-3 is involved in cyclosporine A (CsA)- and FK506-induced apoptosis in PC12 cells. CsA and FK506 increased apoptotic cell death with morphological changes characterized by cell shrinkage and nuclear condensation or fragmentation. Nerve growth factor (NGF) completely blocked cell death. Caspase-3 activation was accompanied by CsA- and FK506-induced cell death and inhibited by NGF. GSK-3 inhibitors such as alsterpaullone and SB216763 prevented CsA- and FK506-induced apoptosis. These results suggest that CsA and FK506 induce caspase-dependent apoptosis and that GSK-3 activation is involved in CsA- and FK506-induced apoptosis in PC12 cells.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10565-007-0192-7DOI Listing

Publication Analysis

Top Keywords

fk506-induced apoptosis
16
csa- fk506-induced
16
apoptosis pc12
12
pc12 cells
12
cell death
12
csa fk506
8
apoptosis
5
cyclosporine fk506-induced
4
cells purpose
4
purpose study
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!